Genomic Alterations in Sporadic Pituitary Tumors

From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal

(2017) S L Asa et al.   ENDOCRINE-RELATED CANCER

Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary Tumors

(2017) Wenya Linda Bi et al.   ENDOCRINOLOGY

Hyperfractionated high-dose proton beam radiotherapy for clival chordomas after surgical removal

(2016) Yasutaka Hayashi et al.   BRITISH JOURNAL OF RADIOLOGY

The genome-wide mutational landscape of pituitary adenomas

(2016) Zhi-Jian Song et al.   CELL RESEARCH

Landscape of Genomic Alterations in Pituitary Adenomas

(2016) Wenya Linda Bi et al.   CLINICAL CANCER RESEARCH

Recurrent gain-of-function USP8 mutations in Cushing's disease

(2015) Zeng-Yi Ma et al.   CELL RESEARCH

Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas

(2015) Cristina L Ronchi et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor

(2015) Simon J. B. Aylwin et al.   Pituitary

BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma

(2014) Sarah Jane Larkin et al.   ACTA NEUROPATHOLOGICA

Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas

(2014) Priscilla K Brastianos et al.   NATURE GENETICS

Mutations in the deubiquitinase gene USP8 cause Cushing's disease

(2014) Martin Reincke et al.   NATURE GENETICS

Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation

(2014) Giampaolo Trivellin et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Novel Mutation in the Upstream Open Reading Frame of the CDKN1B Gene Causes a MEN4 Phenotype

(2013) Gianluca Occhi et al.   PLoS Genetics

Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds

(2012) Maria A Tichomirowa et al.   ENDOCRINE-RELATED CANCER

The pituitary tumour epigenome: aberrations and prospects for targeted therapy

(2012) Kiren Yacqub-Usman et al.   Nature Reviews Endocrinology

Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations

(2012) Keith T. Flaherty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib

(2012) Jeffrey A. Sosman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

(2010) Keith T. Flaherty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Menin, Histone H3 Methyltransferases, and Regulation of Cell Proliferation: Current Knowledge and Perspective

(2008) Xinjiang Wu et al.   CURRENT MOLECULAR MEDICINE